Paediatric Early Rehabilitation/Mobilisation During InTensive Care
PERMIT
1 other identifier
observational
150
1 country
1
Brief Summary
In the UK, critical illness or injury affects about 19,000 Children and Young Persons (CYP) every year who are admitted to the paediatric intensive care unit (PICU) to receive life-sustaining treatments. Although survival rates from PICU are at an all-time high (\>96%), low levels of mortality have been offset by an increase in morbidity. The impact of being critically ill and exposed to the PICU is multiple. Weakness, cognitive impairment, organ dysfunction, and psychological problems have been reported to emanate from deconditioning. Subsequently, post-PICU many CYP experience significant and residual physical, cognitive, and psychosocial morbidities that impact on their quality of life. The contemporary focus has turned to the development, testing, and implementation of interventions to minimize the harmful effects of critical care and maximize patient outcomes. Early rehabilitation and/or mobilisation (ERM) encompasses patient-tailored interventions, delivered individually or in a bundled package, provided by health professionals from multiple disciplines and care-givers within intensive care settings to promote recovery, both physical (e.g. movement, functional activities, ambulation) and non-physical (e.g. speech, play, psychological, cognitive). Rehabilitation has been shown to improve quality of life and patient outcomes; reduce health inequalities, and make significant savings to the health care system. Benefits have been demonstrated in the use of ERM in adult ICU populations in relation to patient outcomes as well as healthcare utilization. Studies also indicate that the intervention is safe and feasible, reduces delirium and increases ventilator-free days, improves day-to-day functioning and reduces hospital readmissions. However, in the United Kingdom (UK), the understanding of current ERM practices (including content, barriers, facilitators, feasibility, and safety) and their impact on the outcomes of pediatric ICU patients is limited. This has stifled an evidence-based approach to ERM which has resulted in disparity in the adoption and utilization of ERM interventions in PICUs across the UK. To address this critical gap, the first phase of a four-phase program of the PERMIT study will generate evidence of current PICU ERM practices by conducting a survey and an observational study. The second phase of the study will involve conducting qualitative workshops to develop a prototype ERM program. Qualitative workshops will also be conducted among key stakeholders (clinicians, parents, CYP) to inform the design of an ERM intervention. The third phase will investigate this ERM program in a pilot study in UK PICUs and finally, the efficacy of the intervention will be tested using a large scale, definitive randomized controlled trial (RCT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedStudy Start
First participant enrolled
October 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedOctober 1, 2019
August 1, 2019
1 month
August 14, 2019
September 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of early rehabilitation and/or mobilisation (ERM) delivered on Day 3 post PICU admission
The prevalence and scope of ERM will be described as the proportion of patients with any 'active interaction' delivered on Day 3 post-admission.
3 weeks
Secondary Outcomes (5)
Incidence rates and ratios of the number of ERM interventions from Day 3 to Day 10 post PICU admission
3 weeks
The cumulative prevalence of ERM for each day in PICU after Day 3 up to Day 10 post-admission
3 weeks
Factors associated with variability of early rehabilitation and/or mobilisation (ERM) delivery
3 weeks
To evaluate predictors of ERM provided on Day 3 post-PICU-admission
3 weeks
Dose of ERM per day of PICU admission
3 weeks
Eligibility Criteria
All Children and Young Persons (CYP) (0-\<16 years) admitted to paediatric itnesive care units for 3 days or more
You may qualify if:
- All Children and Young Persons (CYP) (0-\<16 years)
- Admitted to PICU
- Remain within PICU on day 3 post-admission
You may not qualify if:
- Local decision by PI or treating clinical team not to include patient
- Parent or guardian choose to opt out.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Birminghamlead
- University of Nottinghamcollaborator
- Newcastle Universitycollaborator
- Northumbria Universitycollaborator
- University of Cambridgecollaborator
- University of Leedscollaborator
- Imperial College Londoncollaborator
Study Sites (1)
Birmingham Women's and Children's Hospital PICU
Birmingham, West Midlands, B4 6NH, United Kingdom
Related Publications (1)
Scholefield BR, Menzies JC, McAnuff J, Thompson JY, Manning JC, Feltbower RG, Geary M, Lockley S, Morris KP, Moore D, Pathan N, Kirkham F, Forsyth R, Rapley T. Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study. Health Technol Assess. 2023 Nov;27(27):1-155. doi: 10.3310/HYRW5688.
PMID: 38063184DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Barnaby Scholefield, Dr
Birmingham Women's and Children's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2019
First Posted
October 1, 2019
Study Start
October 28, 2019
Primary Completion
November 30, 2019
Study Completion
October 31, 2020
Last Updated
October 1, 2019
Record last verified: 2019-08